Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 3.
doi: 10.1097/HEP.0000000000001219. Online ahead of print.

Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter study

Martin A Kabelitz  1 , Lukas Hartl  2   3 , Golda Schaub  4 , Anja Tiede  1   5 , Hannah Rieland  1 , Andrea Kornfehl  2   3 , Peter Hübener  4 , Mathias Jachs  2   3 , Jan Hinrichs  6 , Sarah L Schütte  1 , Christoph Riedel  7 , Jim B Mauz  1 , Tammo L Tergast  1 , Bernhard C Meyer  6 , Peter Bannas  7 , Julia Kappel  2   3 , Heiner Wedemeyer  1   5   8 , Johannes Kluwe  4   9 , Felix Piecha  4 , Thomas Reiberger  2   3 , Lisa Sandmann  1   5 , Benjamin Maasoumy  1   5
Affiliations

Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter study

Martin A Kabelitz et al. Hepatology. .

Abstract

Background and aims: Clinically significant portal hypertension in patients with liver cirrhosis can lead to refractory ascites. A TIPS treats clinically significant portal hypertension but may cause overt hepatic encephalopathy (oHE). Our aim was to determine the optimal reduction of the portal pressure gradient (PPG) through TIPS to control ascites without raising oHE risk.

Approach and results: This multicenter study screened 1509 patients from 3 European centers (Hannover, Vienna, and Hamburg) undergoing TIPS implantation between 2000 and 2023. Patients with TIPS indications other than refractory ascites/hepatic hydrothorax, vascular liver disease, HCC, or insufficient PPG data were excluded. PPG was measured before and after TIPS insertion. Outcome data were assessed up to 1 year after TIPS insertion. Analyses were conducted utilizing a modern machine learning model, namely a competing-risk random survival forest, partial dependence plots, and competing risk analyses with liver transplantation/death as competitors. The cohort was divided into a 60% derivation and 40% validation cohort. Overall, 729 patients (median MELD: 13 [IQR 10-16], 66% male, 23% oHE before TIPS) were analyzed. The derivation cohort comprised 438 patients, and the validation cohort comprised 291 patients. The optimal PPG reduction, determined by maximally selected Gray statistic and PDP of the random survival forest, was 60%-80%. In this range, patients showed significantly fewer hepatic decompensations due to ascites (HDA) (subdistribution hazard ratio [sHR]: 0.7 [0.52-0.96]) with similar oHE incidences (sHR: 0.92 [0.67-1.27]). The PPG range was confirmed in the validation cohort (HDA: sHR: 0.66 [0.46-0.96]; oHE: sHR: 0.89 [0.61-1.32]).

Conclusions: A targeted PPG reduction of 60%-80% showed significantly reduced HDA without increased oHE risk. Therefore, PPG reduction within this range could be a valid reduction target.

PubMed Disclaimer

References

    1. Pimpin L, Cortez-Pinto H, Negro F, Corbould E, Lazarus JV, Webber L, et al. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69:718–735.
    1. Younossi ZM, Kremer AE, Swain MG, Jones D, Bowlus C, Trauner M, et al. Assessment of fatigue and its impact in chronic liver disease. J Hepatol. 2024;81:726–742.
    1. D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68:563–576.
    1. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII—Renewing consensus in portal hypertension. J Hepatol. 2022;76:959–974.
    1. Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study. Hepatology. 2010;51:1675–1682.

LinkOut - more resources